Opticyte Image News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UW spinout Opticyte lands $4.6M to test device that quickly detects early signs of organ failure
January 12, 2021 at 3:55 pm
Lori Arakaki, Opticyte co-founder and CEO. (Opticyte Photo)
University of Washington biotech spinout Opticyte has landed $2.9 million in federal grants and $1.7 million in seed funding. The Seattle startup is developing a non-invasive technology that can detect oxygen levels in cells in real time.
The Opticyte Cell O
2 Monitor could help in the treatment of sepsis, which is an infection that runs amuck and can cause organs to shut down, resulting in death. If a sepsis patient sees their cellular oxygen levels drop, it can be an indication of the onset of organ failure. ....

United States , Kenneth Schenkman , Daniel Henning , Lori Arakaki , Edwards Lifesciences , Venture Fund , Us Centers For Disease , University Of Washington , Seattle Harborview Medical Center , National Institutes Of Health , World Health Organization , Opticyte Photo , Disease Control , Harborview Medical , Seattle Children , Opticyte Image , Starfish Medical , National Institutes , ஒன்றுபட்டது மாநிலங்களில் , கெநெத் ஸ்ச்செங்க்மன் , டேனியல் கோழி , எட்வர்ட்ஸ் ஆயுள் அறிவியல் , துணிகர நிதி , எங்களுக்கு மையங்கள் க்கு நோய் , பல்கலைக்கழகம் ஆஃப் வாஷிங்டன் , சீட்டில் துறைமுக பார்வை மருத்துவ மையம் ,